BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2350583)

  • 1. Duration of response after interferon treatment of hairy cell leukemia.
    Mick R; Ratain MJ; Golomb HM
    Blood; 1990 Jun; 75(12):2465-7. PubMed ID: 2350583
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alpha-2A.
    Lishner M; Lang R
    Blood; 1990 Sep; 76(5):1055. PubMed ID: 2393713
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferons.
    Betcher D; Burnham N
    J Assoc Pediatr Oncol Nurses; 1989; 6(2):43-6. PubMed ID: 2661811
    [No Abstract]   [Full Text] [Related]  

  • 4. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.
    Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem E
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):7-9. PubMed ID: 3057646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of hairy cell leukemia with interferon].
    Brünig K; Fülle HH; Dahmen E; Hellriegel KP
    Onkologie; 1988 Aug; 11(4):159-65. PubMed ID: 3054667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal interferon-alpha doses for hairy cell leukemia.
    Gastl G; Aulitzky W; Tilg H; Thaler J; Berger M; Huber C
    Blood; 1990 Feb; 75(3):812-3. PubMed ID: 2297581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience in treating patients with hairy-cell leukemia with a Soviet genetically engineered interferon].
    Lepkov SV; Kruglova GV; Volkova MA; Demina EA
    Ter Arkh; 1989; 61(7):133-6. PubMed ID: 2588131
    [No Abstract]   [Full Text] [Related]  

  • 9. Hairy cell leukemia: follow-up after completion of alpha interferon treatment.
    Castaigne S; Sigaux F; Degos L; Flandrin G
    Nouv Rev Fr Hematol (1978); 1989; 31(5):321-5. PubMed ID: 2587199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy.
    Pangalis GA; Boussiotis VA; Kittas C; Panayiotidis PG; Loukopoulos D; Fessas P; Mitsoulis-Mentzikoff C
    Blood; 1991 Sep; 78(5):1385. PubMed ID: 1878598
    [No Abstract]   [Full Text] [Related]  

  • 11. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
    Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
    Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
    Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
    J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UCLA experience with type I interferons in hairy cell leukemia.
    Glaspy JA; Jacobs AD; Golde DW
    Leukemia; 1987 Apr; 1(4):323-6. PubMed ID: 3312839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.
    Steis RG; VanderMolen LA; Lawrence J; Sing G; Ruscetti F; Smith JW; Urba WJ; Clark J; Longo DL
    Br J Haematol; 1990 May; 75(1):133-5. PubMed ID: 2375913
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon in the treatment of hairy-cell leukemia.
    Ahmed S; Rai KR
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubular confronting cisternae in hairy cells following interferon therapy.
    Rinderknecht BP; Litzistorf Y; Hurwitz N; Sauter G; Gudat F; Denz MD; Ludwig C
    Ann Oncol; 1990 Nov; 1(6):451. PubMed ID: 2083192
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.
    Stratta P; Canavese C; Dogliani M; Thea A; Degani G; Mairone L; Vercellone A
    Ren Fail; 1993; 15(4):559-61. PubMed ID: 8210571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia.
    Ozer H; Golomb HM; Zimmerman H; Spiegel RJ
    J Natl Cancer Inst; 1989 Apr; 81(8):594-602. PubMed ID: 2495367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.